Cargando…
Identification of the first highly selective inhibitor of human lactate dehydrogenase B
Lactate dehydrogenase (LDH) catalyses the conversion of pyruvate to lactate and NADH to NAD(+); it has two isoforms, LDHA and LDHB. LDHA is a promising target for cancer therapy, whereas LDHB is necessary for basal autophagy and cancer cell proliferation in oxidative and glycolytic cancer cells. To...
Autores principales: | Shibata, Sachio, Sogabe, Satoshi, Miwa, Masanori, Fujimoto, Takuya, Takakura, Nobuyuki, Naotsuka, Akihiko, Kitamura, Shuji, Kawamoto, Tomohiro, Soga, Tomoyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560939/ https://www.ncbi.nlm.nih.gov/pubmed/34725423 http://dx.doi.org/10.1038/s41598-021-00820-7 |
Ejemplares similares
-
Succinate dehydrogenase B-deficient cancer cells are highly sensitive to bromodomain and extra-terminal inhibitors
por: Kitazawa, Satoshi, et al.
Publicado: (2017) -
Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases
por: Han, Jung Ho, et al.
Publicado: (2023) -
l-Lactate treatment by photosynthetic cyanobacteria expressing heterogeneous l-lactate dehydrogenase
por: Kato, Yuichi, et al.
Publicado: (2023) -
Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer
por: Ikeda, Asami, et al.
Publicado: (2020) -
NAD-dependent lactate dehydrogenase catalyses the first step in respiratory utilization of lactate by Lactococcus lactis()
por: Zhao, Rui, et al.
Publicado: (2013)